These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10363970)

  • 21. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
    Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
    Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of estrogen receptor coregulators during human breast tumorigenesis.
    Murphy LC; Simon SL; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson PH
    Cancer Res; 2000 Nov; 60(22):6266-71. PubMed ID: 11103781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle control of BRCA2.
    Vaughn JP; Cirisano FD; Huper G; Berchuck A; Futreal PA; Marks JR; Iglehart JD
    Cancer Res; 1996 Oct; 56(20):4590-4. PubMed ID: 8840967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of alternately spliced messenger RNA of the luteinizing hormone receptor and stability of the follicle-stimulating hormone receptor messenger RNA in granulosa cell tumors of the human ovary.
    Reinholz MM; Zschunke MA; Roche PC
    Gynecol Oncol; 2000 Nov; 79(2):264-71. PubMed ID: 11063655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
    Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
    Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
    Poola I; Speirs V
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
    Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
    Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.
    Leygue E; Dotzlaw H; Watson PH; Murphy LC
    Br J Cancer; 1999 May; 80(3-4):379-82. PubMed ID: 10408841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
    Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
    Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
    Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
    J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression.
    Su LK; Wang SC; Qi Y; Luo W; Hung MC; Lin SH
    Oncogene; 1998 Nov; 17(18):2377-81. PubMed ID: 9811469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
    Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
    Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of vascular endothelial cell growth factor and its receptor mRNA in breast cancer tissues].
    Liu X; Fan P; Wang S; Wu ZY
    Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):119-21. PubMed ID: 12783674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.